Hepatitis D virus

Annals of Saudi Medicine

Volumn 16, Issue 2, 1996, Pages 184-192

  Elzouki, Abdul Nasser Y ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

CHRONIC LIVER DISEASE; CLINICAL FEATURE; DELTA AGENT HEPATITIS; HEPATITIS DELTA VIRUS; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY; VIRUS PATHOGENESIS;

EID: 0029953086     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen/antibody system (delta/anti-delta) associated with hepatitis B virus in the liver and in the serum of HBsAg carriers. Gut 1977,18:997-1002.
2. Branch AD, Levine BJ, Robertson HD. The brotherhood of circular RNA pathogens: viroids, circular satellites, and the delta agent. Semin Virol 1990;1:143-52.
3. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence, and expression of the hepatitis delta viral genomic. Nature 1986;323:508-14.
4. Makino S, Chang MF, Shieh CK, et al. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature 1987;329:343-6.
5. Kos A, Dijkema R, Arnberg AC, Van der Merde PH, Schelekens H. The HDV possesses a circular RNA. Nature 1986;323:558-60.
6. Bonino F, Hoyer B, Shih JW, et al. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun 1984,43:1000-5.
7. Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol 1986;58:945-50.
8. Bergmann KF, Gerin JL. Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis 1986;154:702-6.
9. Lai MM. Molecular biologic and pathogenetic analysis of hepatitis delta virus. J Hepatol 1995;22(suppl. 1):127-31.
10. Sharmeen I, Kuo MY-P, Dinter-Gottlieb G, Taylor J. The antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol 1988;62:2674-9.
11. Hess G. Virological and serological aspects of hepatitis B and the delta agent. Gut 1993;Suppl: S1-S5.
12. Halpern MS, England JM, Deery DT, Petcu DJ, Mason WS, Molnar-Kimber KL. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Peking ducks infected with duck hepatitis B virus. Proc Nad Acad Sci USA 1983;80:4865-9.
13. Pasquinelli C, Laure F, Chatenoud L, et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 1986;3:95-103.
14. Ponzetto A, Cote PJ, Popper H, et al. Transmission of the hepatitis B virus-associated delta agent to the Eastern woodchuck. Proc Natl Acad Sci. USA 1984;81:2208-12.
15. Cole SM, Gowans EJ, Macnaughton TB, Hall PM, Burrell CJ. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology 1991;13:845-51.
16. Guilhot S, Huang SN, Xia YP, La Monica N, Lai MMC, Chisari FV. Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol 1994;68:1052-8.
17. Niro GA, Casey JL, Andriulli A, Smedile A, Rizzetto M, Gerin JL. Chronic delta infection in Italy. Analysis of genotype. Hepatology 1994;20:309A.
18. Crivelli O, Lavarini C, Chiaberge E, et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (∂) agent. Clin Exp Immunol 1983;54:232-8.
19. Zauli D, Crespi C, Bianchi FB, Craxi A, Pisi E. Autoimmunity in chronic liver disease caused by hepatitis delta virus. J Clin Path 1986;39:897-9.
20. Wesierska-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamin C in chronic hepatitis delta virus infection. Hepatology 1990;12:1129-33.
21. Zanger UM, Hauri HP, Loeper J, et al. Antibodies against human cytochrome 450 db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 1988;27:8256-60.
22. Manns M, Johnson EF, Griffin KJ, et al. The major target antigen of liver-kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cylochrome P450 db1. J Clin Invest 1989;83:1066-72.
23. Beaune P, Dansette PM, Mansuy D, et al. Human antiendoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987;84:551-5.
24. Philipp T, Sträub P, Durazzo M, Tukey RH, Manns MP. Molecular analysis of autoantigens in hepatitis D. J Hepatol 1995;22(suppl. 1):132-5.
25. Ljunggern KE, Hansson BG. Fulminant delta hepatitis among Swedish drug addicts. Scand J Infect Dis 1986;18:397-400.
26. Taylor J, Mason W, Summers J. Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol 1987;61:1891-5.
27. Ottobelli A, Salizzoni M, Cornu C, et al. Patterns of HDV reinfection in liver transplantation. J Hepatol 1989;9(suppl 1):S68.
28. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology 1985;5:188-91.
29. Rizzetto M. The delta agent. Hepatology 1983;3:729-37.
30. Rizzetto M, Verme G. Delta hepatitis: present status. J Hepatol 1985;1:187-93.
31. Bonino F, Caporaso N, Dentico P, et al. Familial clustering and spreading of hepatitis delta infection. J Hepatol 1985;1:221-6.
32. Wu JC, Lee SD, Govindarajan S, et al. Sexual transmission of hepatitis D virus infection in Taiwan. Hepatology 1990;11:1057-61.
33. Rizzetto M, Shih J, Gocke DJ, Purcell RH, Verme G, Gerin JL. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet 1979;2:986-90.
34. Rizzetto M, Purcell RH, Gerin JL. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1980;1:1215-9.
35. Nordenfelt E, Hansson BG, Al-Nakib B, Alkandari S, Al-Nakib W. Frequency of delta agent infection in Kuwait. J Infect Dis 1983;148:768.
36. Cronberg S, Hansson BG, Thermos M, Moestrup T, Sow AM. Hepatitis D (delta agent) in primary hepatocellular carcinoma and liver disease in Senegal. Liver 1984;4:275-9.
37. Greenfield C, Farci P, Osidiana V, et al. Hepatitis delta virus infection in Kenya: its geographic and tribal distribution. Am J Epid 1986;123:416-23.
38. Halder SC, Monzon MD, Ponzetto A, et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984;100:339-44.
39. Polish LB, Gallagher M, Fields HA, Halder SC. Delta hepatitis. Molecular biology and clinical and epidemiologic features. Clin Microbiol Rev 1993;6:211-29.
40. Hansson BG, Moestrup T, Widell A, Nordenfelt E. Infection with delta agent in Sweden: introduction of a new hepatitis agent. J Infect Dis 1982;146:472-8.
41. Govindarajan S, Chin KP, Redeker AG, Peter RL. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984;86:1417-20.
42. Govindarajan S, Valinluck B, Peters RL. Relapse of acute B viral hepatitis: role of delta agent. Gut 1986;27:19-27.
43. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980;141:590-602.
44. Moestrup T, Hansson BG, Widell A, Nordenfelt E. Clinical aspects of delta infection. BMJ 1983;286:87-90.
45. Arico S, Aragona M, Rizzetto M, et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet 1985;2:356-8.
46. Buti M, Esteban R, Allende H, et al. Clinical and serological outcome of acute delta infection. J Hepatol 1987;5:59-64.
47. Mas A, Buti M, Esteban R, et al. Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis. Hepatology 1990;11:1062-5.
48. Rizzetto M, Verme G, Gerin JL, Purcell RH. Hepatitis delta virus disease. Progress in liver disease 1986:417-31.
49. Lin H-H, Liaw Y-F, Chen T-J, et al. Natural course of patients with chronic type B hepatitis following acute delta hepatitis superinfection. Liver 1989;9:129-34.
50. Ponzetto P, Negro F, Popper H, et al. Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees. Hepatology 1988;8:1655-61.
51. Negro F, Bergmann KF, Baroudy BM, et al. Chronic hepatitis B virus carrier chimpanzees experimentally superinfected with HDV. J Infect Dis 1988;158:151-9.
52. Rizzetto M, Vernie G, Recchia S, et al. Chronic hepatitis in carriers of HBsAg with intrahepatic expression of the delta antigen. Ann Intern Med 1983;98:437-41.
53. Farci P, Barbera C, Novone C, et al. Infection with the delta agent in children. Gut 1985;26:4-7.
54. Bortolotti F, Calzia R, Cadrobbi P, et al. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood. J Pediat 1986;108:224-7.
55. Amazigo UO, Chime A. Infection with hepatitis delta virus in eastern Nigeria: a preliminary study. Trans R Soc Trop Med Hyg 1988;82:905.
56. Soubiran G, Le Bras M, Marini P, Sekou H. High HBsAg and anti-delta carrier rate among asymptomatic Africans living on the campus of the University of Niamey, Niger. Trans R Soc Trop Med Hyg 1987;81:998-1000.
57. Roingeard P, Sankale J-L, Dubois F, et al. Infection due to hepatitis delta virus in Africa: report from Senegal and review. Clin Infect Dis 1992;14:510-14.
58. Belabbes El-H. The delta virus in Algeria. In: Rizzetto M, Gerin JL, Purcell, eds. The hepatitis delta virus its infection. New York: Alan R Liss 1987:443-4.
59. El-Zayadi A, Ponzetto A, Salim O, Lavarini C, Rizzetto M. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterol 1988;35:313-5.
60. Rassam SW, Omar AR, Niazi MM. Delta virus infection in asymptomatic HBV carriers and in patients with chronic liver disease in Iraq. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss Inc., 1987:421-4.
61. Toukan AU, Abu-El-Rub OA, Abu-Laban SA, et al. The epidemiologic and clinical outcome of hepatitis D viral (delta) infection in Jordan. Hepatology 1987;7:1340-5.
62. Farci P, Burroughs AK, Thomas HC, Shamma's M. Delta hepatitis in Lebanon: prevalence studies and a report on six siblings with chronic delta-positive active hepatitis. J Hepatol 1987;4:224-8.
63. El-Hazmi MAF. Anti-delta in HBsAg-positive Saudis. Saudi Med J 1989;10:286-9.
64. Sheth KV, Schifano J, Carr A. Anti-delta virus antibody in sera positive for HBsAg in male Saudi blood donors. Ann Saudi Med 1989;9:463-5.
65. Ayed K, Gorgi Y, Pichoud C, Trepo C. Prevalence of HD Ag anti-HD by radioimmunoassay in acute and chronic HBV infections in Tunisia. In: Rizzetto M, Gerin JL, Purcell RH, eds. The hepatitis delta virus and its infection. New York: Alan R. Liss, 1987:441-2.
66. Novick DM, Farci P, Croxson TS, et al. Effect of human immunodeficiency- virus on the increased severity of liver disease associated with delta hepatitis. Gastroenterology 1988;94:A578.
67. Cassidy WM, Govindarajan S, Gupta S, Valinluck B, Redeker AG. Influence of HIV on chronic hepatitis B and D infection. Hepatology 1989:10:690.
68. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992;15:578-83.
69. Elzouki A-N. Therapies for human immunodeficiency virus (HIV). Eur J Intern Med 1995;6:85-94.
70. Shattock AG, Finlay H, Hillary IB. Possible reactivation of hepatitis D with chronic delta antigenemia by human immunodeficiency virus. Br Med J 1987;294:1656-7.
71. De Pouplana M, Garcia-Samaniego J, Soriano V, Enriquez A, Munoz F, Gonzalez-Lahoz J. More severe course of chronic hepatitis D in HIV-infected patients. Hepatology 1994;20:343A.
72. Babudieri S, Cossu PA, Tocco A, et al. Course of patients co-infected with HIV and hepatotropic viruses. Hepatology 1994;20:255A.
73. Gitnick G. Hepatitis infection in immunocompromised patients. Gastroenterol Clin N Am 1994;23:515-21.
74. Caredda F, Antinori S, Pastecchia C, et al. Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis 1989;159:977-9.
75. Dubois F, Goudeau A. Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays. J Clin Microbiol 1988;26:1339-42.
76. Negro F, Rizzetto M. Diagnosis of hepatitis delta virus infection. J Hepatol 1995;22(suppl 1):136-9.
77. Aragona M, Macagno S, Caredda F, et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1987;1:478-80.
78. Grippon P, Ribiere O, Cadranel JF, et al. Long-term delta antigenemia without appearance of delta antibody in two immunodeficiency patients. Lancet 1987;1:1021.
79. Bergmann K, Gerin JL. Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis 1986;154:702-6.
80. Buti M, Esteban R, Jardi R, et al. Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication. Hepatology 1989;10:907-10.
81. Madejon A, Castillo I, Bartolome E, et al. Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection. J Hepatol 1990;11:381-4.
82. Buti M, Esteban R, Jardi R, et al. Serological diagnosis of acute delta hepatitis. J Med Virol 1986;18:81-5.
83. Jardi R, Buti M, Rodriguez-Frias F, et al. Clinical significance of two forms of IgM antibody to hepatitis delta virus. Hepatology 1991;14:25-8.
84. Negro F, Bergmann KF, Baroudy BM, et al. Chronic hepatitis delta virus (HDV) infection in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV. J Infect Dis 1988;158:151-9.
85. Recchia S, Rizzi R, Acquaviva F, et al. Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica 1981;73:773-7.
86. Di Bisceglie AM, Negro F. Diagnosis of hepatitis delta virus infection. Hepatology 1989;10:1014-6.
87. Verme G, Amoroso P, Lettieri G, et al. A histological study of hepatitis delta virus liver disease. Hepatology 1986;6:1303-7.
88. Negro F, Baldi M, Bonino F, et al. Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease. J Hepatol 1988;6:8-14.
89. Rasshoffer R, Buti M, Esteban R, Jardi R, Roggendorf M. Demonstration of HDV-RNA in patients with chronic hepatitis. J Infect Dis 1988;157:191-5.
90. Negro F, Bonino F, Di Bisceglie A, Hoofnagle J, Gerin JL. Intrahepatic markers of hepatitis delta virus infection. A study by in situ hybridization. Hepatology 1989;10:916-20.
91. Pacchioni D, Negro F, Chiaberge E, Rizzetto M, Bonino F, Bussolati G. Detection of hepatitis delta virus RNA by a non-radioactive in situ hybridization procedure. Hum Pathol 1992;23:557-61.
92. Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter, randomized, controlled trial. N Engl J Med 1989;321:1501-6.
93. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
94. Perrillo PR, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
95. Actis GC, Maran E, Rizzetto M. Treatment of patients with delta hepatitis using interferon. Arch Intern Med 1986;146:2081.
96. Farci P, Mandas A, Coiana A, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88-94.
97. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human interferon-alfa in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology 1991;13:1052-6.
98. Madejon A, Cotonat T, Bartolome J, Castillo I, Carreno V. Treatment of chronic hepatitis D virus infection with low and high doses of interferon alfa-2a: Utility of polymerase chain reaction in monitoring antiviral response. Hepatology 1994;19:1331-6.
99. Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98:437-41.
100. Rizzetto M, Macagno S, Chiaberge E, et al. Liver transplantation in hepatitis delta virus disease. Lancet 1987;2:469-71.
101. Ottobrelli A, Marzano A, Smedile A, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991;101:1641-55.
102. Samuel D, Bismuth H, Benhamou JP. Liver transplantation in cirrhosis due to hepatitis D virus infection. J Hepatol 1993;17(suppl 3):S154-6.
103. Grendele M, Colledan M, Gudell B. Does the experience with liver transplantation suggest that hepatitis delta virus is not cytopathic? Transplant Proc 1990;22:1551-3.
104. Mason AL, Wick M, White HM, et al. Increased hepatitis expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993;105:237-44.
105. Samuel D, Zignego L, Fabian B, et al. Medium-term results of liver transplantation in cirrhosis due to hepatitis delta virus (HDV) infection. J Hepatol 1988;7(suppl.):75A.